#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastrointestinal stromal tumour Penile squamous cell carcinoma Congenital cystic kidney disease Ovarian cancer Endocrine ophthalmopathy Astrocytoma malignant Lymphoma Vernal keratoconjunctivitis Familial haemophagocytic lymphohistiocytosis Metastases to central nervous system Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Mantle cell lymphoma stage III Immune thrombocytopenia Acute hepatic failure Anal cancer More trials…

    Learn about Rare Diseases

    Angiosarcoma recurrent Primary biliary cholangitis – Basic Information Angelman’s syndrome – Basic Information Advanced systemic mastocytosis – Treatment Systemic sclerosis pulmonary – Treatment Isodicentric chromosome 15 syndrome – Diagnostics Langerhans cell sarcoma – Diagnostics Bronchopulmonary dysplasia – Basic Information Prader-Willi syndrome – Diagnostics Phenylketonuria – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nebivolol Xxb750 L-PHENYLALANINE Dexamethasone Sodium Phosphate Bilastine TIL CELLS Baxdrostat Methohexital Sodium Neratinib Oxaliplatin Ecopipam Hydrochloride Metyrapone Brexpiprazole Fumarate Anhydrous Azithromycin HALOBETASOL PROPIONATE Goserelin Acetate SOFOSBUVIR Sasanlimab Amantadine Hemisulfate Vinorelbine Tartrate More therapies…

    Learn about Your Condition

    Chronic lymphocytic leukaemia Hepatoblastoma Autoimmune hepatitis Spinal cord injury Leiomyosarcoma Mixed-type liposarcoma Peripheral artery thrombosis Andersen-Tawil syndrome Anal cancer recurrent Ventricular fibrillation Metastatic glioma Cardiovascular disorder Brain cancer metastatic Alport's syndrome Chondrocalcinosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Bevacizumab Dose Equivalence for Patients with Ovarian, Fallopian Tube, or Peritoneal Cancer Using Bevacizumab, Olaparib, Carboplatin, and Paclitaxel

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant peritoneal neoplasm
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated Drugs:
    • Bevacizumab
    • Carboplatin
    • Olaparib
    Poland

  • Study on the Safety of LY3884961 for Patients with Type 1 Gaucher Disease

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 9 Expressing Codon-Optimized Human Gba Gene
    • Methylprednisolone
    • Sirolimus
    Germany Spain

  • Study on the Safety and Effectiveness of ApTOLL for Patients with ST Elevation Myocardial Infarction (STEMI)

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Acute myocardial infarction
    • Myocardial infarction
    Investigated Drugs:
    • Aptamer-4Ft
    Spain

  • Study on the Safety and Effectiveness of TARA-002 for Adults with High-Grade Non-Muscle Invasive Bladder Cancer

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Bladder cancer stage 0 with cancer in situ
    • Bladder cancer stage I with cancer in situ
    Investigated Drugs:
    • Streptococcus Pyogenes, Group A, Type 3, Strain Su, Inactivated
    Romania Spain

  • Study on the Effectiveness and Safety of Odronextamab Compared to Standard Treatment in Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Ifosfamide
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Germany Hungary Italy +4

  • Study on the Safety and Effects of AZD9550 for Overweight and Obese Patients with Non-Alcoholic Steatohepatitis (NASH) with or without Type 2 Diabetes

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • AZD6234
    • Azd9550
    • Calcium
    Austria Germany Sweden
Previous Page
1 … 879 880 881 882 883 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!